Advanced effect of curcumin and resveratrol on mitigating hepatic steatosis in metabolic associated fatty liver disease via the PI3K/AKT/mTOR and HIF-1/VEGF cascade-Reference-Cited by-全球学者库

Advanced effect of curcumin and resveratrol on mitigating hepatic steatosis in metabolic associated fatty liver disease via the PI3K/AKT/mTOR and HIF-1/VEGF cascade

Published:2023-09 Issue: Volume:165 Page:115279
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

He Yuhui,Wang Huan,Lin Shiling,Chen Tao^ORCID,Chang Dennis,Sun Yibin,Wang Chenxiang,Liu Yang^ORCID,Lu Yusheng^ORCID,Song Jianyuan^ORCID,Li Shaohua,Xu Wen^ORCID,Lin Yanxiang,Zheng Yanfang^ORCID,Zhou Xian^ORCID,Huang Qiumei,Huang Mingqing

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference46 articles.

1. Regulatory mechanism of HIF-1α and its role in liver diseases: a narrative review;Chu;Ann. Transl. Med.,2022

2. Silencing HIF-1α aggravates non-alcoholic fatty liver disease in vitro through inhibiting PPAR-α/ANGPTL4 singling pathway;He;Gastroenterol. Hepatol.,2021

3. Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: a systematic review and meta-analysis;Fatima;Clin. Res Hepatol. Gastroenterol.,2022

4. MAFLD: renovation of clinical practice and disease awareness of fatty liver;Kawaguchi;Hepatol. Res.,2022

5. Incidence of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression;Orci;Clin. Gastroenterol. Hepatol.,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human diet‐derived polyphenolic compounds and hepatic diseases: From therapeutic mechanisms to clinical utilization;Phytotherapy Research;2023-10-23